TP53 and diffuse large B-cell lymphoma: Frequent occurrence of TP53 alterations has been shown in DLBCL at relapse after therapy with R-CHOP, even if TP53 mutations were absent at the initial diagnosis, suggesting a tendency towards mutations under immunochemotherapy [10].